Other News

GE Healthcare and AMC Health to Partner in Remote Patient Monitoring to Provide Patients with Chronic and Post-Acute Care in the Home

CHICAGO & NEW YORK–(BUSINESS WIRE)–GE Healthcare and AMC Health today announced a collaboration that allows clinicians to offer Remote Patient Monitoring (RPM) as a virtual care solution that extends patient care outside the hospital to the home environment. The combination of GE Healthcare’s acute patient monitoring capabilities in the hospital […]

Treatment of Severe Heart Failure – AI: FineHeart Awarded €2.5 million Grant Under the Prestigious EIC Accelerator Program, the First Part of Blended Financing of up to €17.5 Million for the Development and Clinical Trials of the ICOMS FLOWMAKER®

BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced that it had been awarded a €2.5 million grant by the European Commission […]

Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology

MIAMI LAKES, Fla., Oct. 18, 2022 /PRNewswire/ — Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technologies, today announced its acquisition, subject to customary closing conditions including regulatory approvals, of MedAlliance, a Switzerland-based company at the forefront of transformative drug-eluting balloons. By acquiring MedAlliance, Cordis has the potential to […]

RhythMedix® Expands Monitoring Capabilities of Its RhythmStar® System, the First Wearable Cardiac Monitor with Built-In Cellular Connectivity

Strategic addition of Extended Wear Holter monitoring modality enhances portfolio offering and positions company for accelerated growth MOUNT LAUREL, N.J., Oct. 18, 2022 /PRNewswire/ — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms, today announced expanded modalities for its RhythmStar® System (RhythmStar). The addition of long-term continuous electrocardiogram (ECG) monitoring […]

HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap™ Analysis

HeartFlow is the first and only company to provide non-invasive anatomy, physiology, and plaque information based on coronary computed tomography angiography (CCTA) MOUNTAIN VIEW, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, has received U.S. Food and Drug Administration (FDA) 510(k) clearance on […]

Revamp Medical Announces First Patient Enrolled in Early Feasibility Study, Evaluating Doraya Catheter for Relieving Congestion in Acute Heart Failure (AHF) Patients

Cardiologists at The Christ Hospital in Cincinnati, Ohio, are first in the US to begin testing Doraya as part of an EFS for AHF patients with insufficient response to diuretics NETANYA, Israel, Oct. 18, 2022 /PRNewswire/ — Revamp Medical, a pioneering developer of a percutaneous device for the treatment of acute heart failure (AHF), today announced the enrollment of the […]

Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & System

CARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced submission of pivotal clinical data from the AcQForce Flutter trial designed to gain marketing approval from […]

Aerovate Therapeutics Presents Novel Phase 2b/Phase 3 IMPAHCT Trial Design at CHEST Annual Meeting 2022

Adaptive and efficient trial design may allow for expedited development timeline while maintaining scientific rigor WALTHAM, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE) today presents the design of IMPAHCT (Inhaled iMatinib for Pulmonary Arterial Hypertension Clinical Trial; AV-101-002), a Phase 2b/Phase 3 trial investigating the […]

Elixir Medical Expands Leadership Team With Addition of Alexey Nepogodiev as Executive Vice President, Global Marketing

MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced it has appointed Alexey (Alex) Nepogodiev as Executive Vice President, Global Marketing. Alex possesses more than 20 years of leadership experience in successfully developing new markets and therapies in interventional cardiology, structural heart, and endovascular businesses worldwide. […]